The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

First Page		Document Content
Pharmacology Dermatologic and Ophthalmic Drugs Advisory Committee Center for Drug Evaluation and Research George Yancopoulos Regeneron Ketorolac Food and Drug Administration Pharmaceutical sciences Clinical research		The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 27,06 KB Share Document on Facebook